https://www.saltiki.gr/anthektikos-sti-therapeiame-radienergo-iodiometastatikos-diaforopoiimenos-karkinos-thyreoeidous-kai-tora-ti-kanoume-panellinio-synedrio-2025/ 2025-06-18T15:46:09+00:00 https://www.saltiki.gr/wp-content/uploads/2025/01/52_panellinio_endokrinologiko_synedrio_2025.png https://www.saltiki.gr/pachysarkia-ta-dorean-farmaka-pou-den-prepei-na-dinontai-se-olous/ 2025-06-21T13:14:00+00:00 https://www.saltiki.gr/wp-content/uploads/2024/06/fat.jpg https://www.saltiki.gr/50o-etisio-panellinio-iatriko-synedrio/ 2025-06-21T13:14:07+00:00 https://www.saltiki.gr/wp-content/uploads/2025/06/50_synedrio.png https://www.saltiki.gr/ermineia-ormonikon-apotelesmaton-epi-ti-vasei-periptoseon-panellinio-synedrio-2024/ 2025-06-21T13:14:13+00:00 https://www.saltiki.gr/wp-content/uploads/2025/06/panellinio_sinedrio_2024.png https://www.saltiki.gr/omilia-ston-endorama24-thema-simantikes-dimosiefseis-gia-ton-thyreoeidi-to-2024-patra-ianouarios-2025/ 2025-06-21T13:14:19+00:00 https://www.saltiki.gr/wp-content/uploads/2025/06/endorama24.png https://www.saltiki.gr/medullary-thyroid-cancer-from-molecular-biology-and-therapeutic-pitfalls-to-future-targeted-treatment-perspectives/ 2025-06-21T13:29:03+00:00 https://www.saltiki.gr/wp-content/uploads/2022/07/Saltiki_MTC_TKI_RESIST_EJE220312.jpg https://www.saltiki.gr/small-medullary-thyroid-carcinoma-post-operative-calcitonin-rather-than-tumour-size-predicts-disease-persistence-and-progression/ 2025-06-21T13:29:03+00:00 https://www.saltiki.gr/wp-content/uploads/2014/04/Saltiki_smallMTC_EJE_2014.jpg https://www.saltiki.gr/different-outcomes-in-sporadic-versus-familial-medullary-thyroid-cancer/ 2025-06-21T13:29:03+00:00 https://www.saltiki.gr/wp-content/uploads/2017/07/Saltiki_Different_outcomes_thyroid_cancer_2017.jpg https://www.saltiki.gr/histology-is-more-important-than-persistent-anti-tg-antibodies-for-progression-of-differentiated-thyroid-cancer/ 2025-06-21T13:29:03+00:00 https://www.saltiki.gr/wp-content/uploads/2021/01/Saltiki_Karapanou_antiTg_2021_Clin_Endo.jpg https://www.saltiki.gr/increasing-prevalence-of-papillary-thyroid-carcinoma-in-recent-years-in-greece-the-majority-are-incidental/ 2025-06-21T13:29:04+00:00 https://www.saltiki.gr/wp-content/uploads/2009/12/Saltiki_Alevizaki_PTC_Thyroid.jpg https://www.saltiki.gr/metachronous-appearance-of-second-malignancies-in-medullary-thyroid-carcinoma-mtc-patients-a-diagnostic-challenge-and-brief-review-of-the-literature/ 2025-06-21T13:29:04+00:00 https://www.saltiki.gr/wp-content/uploads/2013/02/Saltiki_MTC_coexistence_ENDOCRINE.jpg https://www.saltiki.gr/high-prevalence-of-exon-8-g533c-mutation-in-apparently-sporadic-medullary-thyroid-carcinoma-in-greece/ 2025-06-21T14:32:57+00:00 https://www.saltiki.gr/wp-content/uploads/2012/01/Saltiki_prevalence_of_exon8.jpg https://www.saltiki.gr/medullary-thyroid-carcinoma-the-influence-of-policy-changing-in-clinical-characteristics-and-disease-progression/ 2025-06-21T14:36:44+00:00 https://www.saltiki.gr/wp-content/uploads/2012/01/Saltiki_MTC_EJE_2012.jpg https://www.saltiki.gr/the-effect-of-obesity-and-dietary-habits-on-oxidative-stress-in-hashimotos-thyroiditis/ 2025-06-21T14:40:41+00:00 https://www.saltiki.gr/wp-content/uploads/2021/07/Saltiki_Obesity_Hashimoto.jpg https://www.saltiki.gr/familial-mtc-with-ret-exon-8-gly533cys-mutation-origin-and-prevalence-of-second-malignancy/ 2025-06-21T14:45:15+00:00 https://www.saltiki.gr/wp-content/uploads/2017/09/Saltiki_exon8_Endocrine_Connections_2017.jpg https://www.saltiki.gr/metastatic-medullary-thyroid-carcinoma-mtc-disease-course-treatment-modalities-and-factors-predisposing-for-drug-resistance/ 2025-06-21T14:52:58+00:00 https://www.saltiki.gr/wp-content/uploads/2022/12/Saltiki_MTC_real_life_Endocrine_2023.jpg https://www.saltiki.gr/local-treatments-and-tkis-efficacy-in-radioiodine-refractory-differentiated-thyroid-carcinoma-patients-a-single-center-experience/ 2025-06-22T18:19:07+00:00 https://www.saltiki.gr/wp-content/uploads/2025/02/Saltiki_rair_and_rel_cancer2025.jpg https://www.saltiki.gr/klironomoumeno-myeloeideskarkinoma-tou-thyreoeidous-mia-asynithisti-metallaxi-pou-pithana-exaplothike-apo-tin-archaia-ellada/ 2025-06-23T13:45:24+00:00 https://www.saltiki.gr/wp-content/uploads/2025/06/hot_spot_Greece-1.png https://www.saltiki.gr/rare-metastatic-sites-in-three-patients-with-rai-refractory-differentiated-thyroid-cancer-dtc/ 2025-07-24T16:21:16+00:00 https://www.saltiki.gr/wp-content/uploads/2025/07/Saltiki_differentiated_thyroid_cancer_DTC.jpg https://www.saltiki.gr/thyroid-eye-disease-as-initial-manifestation-of-graves-disease-following-viral-vector-sars-cov-2-vaccine-report-of-a-case-and-review-of-the-literature/ 2025-08-01T19:53:01+00:00 https://www.saltiki.gr/wp-content/uploads/2023/10/Saltiki_paper_covid_michalaki_2024.jpg https://www.saltiki.gr/en/thyroid-eye-disease-as-initial-manifestation-of-graves-disease-following-viral-vector-sars-cov-2-vaccine-report-of-a-case-and-review-of-the-literature-2/ 2025-08-01T19:53:15+00:00 https://www.saltiki.gr/wp-content/uploads/2023/10/Saltiki_paper_covid_michalaki_2024.jpg https://www.saltiki.gr/en/advanced-rai-refractory-thyroid-cancer-an-update-on-treatment-perspectives-2/ 2025-09-08T18:28:02+00:00 https://www.saltiki.gr/wp-content/uploads/2023/01/Saltiki_rai_r_review_2022.jpg https://www.saltiki.gr/advanced-rai-refractory-thyroid-cancer-an-update-on-treatment-perspectives/ 2025-09-08T18:29:00+00:00 https://www.saltiki.gr/wp-content/uploads/2023/01/Saltiki_rai_r_review_2022.jpg https://www.saltiki.gr/en/increasing-prevalence-of-papillary-thyroid-carcinoma-in-recent-years-in-greece-the-majority-are-incidental-2/ 2025-09-13T18:11:15+00:00 https://www.saltiki.gr/wp-content/uploads/2009/12/Saltiki_Alevizaki_PTC_Thyroid.jpg